Zoeken op naam:
A B C D E F G H I J K L M N O P R S T U V W X Y Z
Himplasia
Himplasia
Himplasia relieves the symptoms of benign prostatic hyperplasia.
Pakket
Prijs
Per Flessen
Sparen
Bestel
30 caps x 1 fles
$43.99
$43.99
$0.00
30 caps x 2 flessen
$69.99
$35.00
$17.98

Productbeschrijving

Common use

Himplasia is an ayurvedic formulation used to improve man's health and relieves the symptoms of benign prostatic hyperplasia. Due to its alpha-adrenoceptor antagonistic and 5-alpha reductase enzyme inhibitory activities this herbal product improves urinary flow rate and reduces post-void residual urine. Himplasia also inhibits proliferation of prostate stroma cells.



Directions

Usual dose of Himplasia is 1-2 tablets taken twice daily with meals. The usage usually continues for three or six months.



Precautions

Use Himplasia with caution if you have hypertension.



Contraindications

Contraindications have not yet been identified.



Missed dose

Take the missed dose as soon as possible. Do not take extra or doubled dose of this herbal product.



Possible side effects

This product is safe for health and has no known side effects.



Storage

Store at room temperature between 59-77 F (15-25 C) away from light and moisture, kids and pets.



Overdose

If you suspect overdose contact your health care advisor as soon as possible.



More information

Gokshura (Tribulus terrestris), Putikaranja (Caesalpinia bonducella), Puga (Areca catechu), Shatavari (Asparagus racemosus), Varuna (Crataeva nurvala), Akika pishti.



Disclaimer

All products presented at this site are not intended to diagnose, treat, cure, or prevent any disease. Don't hesitate to consult your health care practitioner before taking any herbal supplement.

 

GRATIS VERZENDING
GRATIS PILLEN
10% KORTING
Nieuws
2025-03-13
There are three main reasons body is going - money, bureaucracy and control, says Nick Triggle
2025-03-13
It can be taken at home on a daily basis, but it is only patients for who have tried all other options. ...
2025-03-13
Children under five constituted more than 40% of the cases reported in Europe and Central Asia last year.
2025-03-13
Healthcare Improvement Scotland is concerned about treatment at parties organised with unregulated providers.